A
AVIDITY BIOSCIENCES INC
NASDAQ: RNA (Avidity Biosciences, Inc.)
Kemas kini terakhir: 6 jam lalu71.63
0.09 (0.13%)
| Penutupan Terdahulu | 71.54 |
| Buka | 71.61 |
| Jumlah Dagangan | 1,916,946 |
| Purata Dagangan (3B) | 5,192,921 |
| Modal Pasaran | 10,792,902,656 |
| Harga / Jualan (P/S) | 451.36 |
| Harga / Buku (P/B) | 5.73 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 10 Nov 2025 |
| Margin Operasi (TTM) | -8,360.90% |
| EPS Cair (TTM) | -3.00 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -55.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.45% |
| Nisbah Semasa (MRQ) | 16.91 |
| Aliran Tunai Operasi (OCF TTM) | -355.32 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -245.73 M |
| Pulangan Atas Aset (ROA TTM) | -22.47% |
| Pulangan Atas Ekuiti (ROE TTM) | -34.19% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Avidity Biosciences, Inc. | Menaik | Menaik |
AISkor Stockmoo
-0.5
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 2.0 |
| Purata | -0.50 |
|
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 5.17% |
| % Dimiliki oleh Institusi | 112.41% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Ra Capital Management, L.P. | 30 Sep 2025 | 8,641,031 |
| Polar Capital Holdings Plc | 30 Sep 2025 | 2,796,760 |
| Bellevue Group Ag | 30 Sep 2025 | 2,152,862 |
| Casdin Capital, Llc | 30 Sep 2025 | 1,780,000 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 74.00 (TD Cowen, 3.31%) | Pegang |
| Median | 72.00 (0.52%) | |
| Rendah | 62.00 (Roth Capital, -13.44%) | Beli |
| Purata | 69.36 (-3.17%) | |
| Jumlah | 3 Beli, 8 Pegang | |
| Harga Purata @ Panggilan | 62.08 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Chardan Capital | 11 Nov 2025 | 72.00 (0.52%) | Pegang | 70.70 |
| 28 Oct 2025 | 72.00 (0.52%) | Pegang | 69.93 | |
| TD Cowen | 29 Oct 2025 | 74.00 (3.31%) | Pegang | 69.65 |
| RBC Capital | 28 Oct 2025 | 72.00 (0.52%) | Pegang | 69.93 |
| Bernstein | 27 Oct 2025 | 72.00 (0.52%) | Pegang | 70.00 |
| Citigroup | 27 Oct 2025 | 72.00 (0.52%) | Pegang | 70.00 |
| HC Wainwright & Co. | 27 Oct 2025 | 72.00 (0.52%) | Pegang | 70.00 |
| 12 Sep 2025 | 87.00 (21.46%) | Beli | 44.74 | |
| Leerink Partners | 27 Oct 2025 | 72.00 (0.52%) | Pegang | 70.00 |
| Needham | 27 Oct 2025 | 65.00 (-9.26%) | Pegang | 70.00 |
| 10 Sep 2025 | 65.00 (-9.26%) | Beli | 46.40 | |
| Evercore ISI Group | 22 Sep 2025 | 65.00 (-9.26%) | Beli | 42.34 |
| Roth Capital | 17 Sep 2025 | 62.00 (-13.44%) | Beli | 40.06 |
| B of A Securities | 15 Sep 2025 | 65.00 (-9.26%) | Beli | 40.22 |
| Papar semua | ||||
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |